147 related articles for article (PubMed ID: 24254637)
21. A simple method to predict response to immunosuppressive therapy in patients with myelodysplastic syndrome.
Saunthararajah Y; Nakamura R; Wesley R; Wang QJ; Barrett AJ
Blood; 2003 Oct; 102(8):3025-7. PubMed ID: 12829603
[TBL] [Abstract][Full Text] [Related]
22. Paroxysmal nocturnal hemoglobinuria clones in severe aplastic anemia patients treated with horse anti-thymocyte globulin plus cyclosporine.
Scheinberg P; Marte M; Nunez O; Young NS
Haematologica; 2010 Jul; 95(7):1075-80. PubMed ID: 20595102
[TBL] [Abstract][Full Text] [Related]
23. Treatment of children with refractory anemia: the Japanese Childhood MDS Study Group trial (MDS99).
Hasegawa D; Manabe A; Yagasaki H; Ohtsuka Y; Inoue M; Kikuchi A; Ohara A; Tsuchida M; Kojima S; Nakahata T;
Pediatr Blood Cancer; 2009 Dec; 53(6):1011-5. PubMed ID: 19499580
[TBL] [Abstract][Full Text] [Related]
24. Antithymocyte globulin for treatment of the bone marrow failure associated with myelodysplastic syndromes.
Molldrem JJ; Leifer E; Bahceci E; Saunthararajah Y; Rivera M; Dunbar C; Liu J; Nakamura R; Young NS; Barrett AJ
Ann Intern Med; 2002 Aug; 137(3):156-63. PubMed ID: 12160363
[TBL] [Abstract][Full Text] [Related]
25. Cyclosporine Therapy in Patients with Transfusion-independent Non-severe Aplastic Anemia: A Retrospective Analysis.
Matsuda K; Koya J; Arai S; Nakazaki K; Nakamura F; Kurokawa M
Intern Med; 2019 Feb; 58(3):355-360. PubMed ID: 30146592
[TBL] [Abstract][Full Text] [Related]
26. [Successful immunosuppressive therapy for a patient with hypoplastic myelodysplastic syndrome].
Takanashi M; Kadono Y; Tabata Y; Hibi S
Rinsho Ketsueki; 1999 Oct; 40(10):1093-9. PubMed ID: 10565227
[TBL] [Abstract][Full Text] [Related]
27. Successful treatment of severe aplastic anemia in children using standardized immunosuppressive therapy with antithymocyte globulin and cyclosporine A.
Goldenberg NA; Graham DK; Liang X; Hays T
Pediatr Blood Cancer; 2004 Dec; 43(7):718-22. PubMed ID: 15390303
[TBL] [Abstract][Full Text] [Related]
28. Clinical outcomes of immunosuppressive therapy for severe aplastic anemia patients with absolute neutrophil count of zero.
Liu J; Lu XY; Cheng L; Yang Y; Lin SY; Yin H; Liu XQ; Wu XM; He GS
Hematology; 2019 Dec; 24(1):492-497. PubMed ID: 31221029
[No Abstract] [Full Text] [Related]
29. Use of immunosuppressive therapy for management of myelodysplastic syndromes: a systematic review and meta-analysis.
Stahl M; Bewersdorf JP; Giri S; Wang R; Zeidan AM
Haematologica; 2020 Jan; 105(1):102-111. PubMed ID: 31004015
[TBL] [Abstract][Full Text] [Related]
30. Successful immunosuppressive therapy for a child with Myelodysplastic syndrome.
Orimoto M; Maeda M; Cai LZ; Hayakawa J; Ueda T; Migita M; Asano T
Med Pediatr Oncol; 2003 May; 40(5):334-5. PubMed ID: 12652627
[No Abstract] [Full Text] [Related]
31. Anti-thymocyte globulin plus etanercept as therapy for myelodysplastic syndromes (MDS): a phase II study.
Scott BL; Ramakrishnan A; Fosdal M; Storer B; Becker P; Petersdorf S; Deeg HJ
Br J Haematol; 2010 Jun; 149(5):706-10. PubMed ID: 20331464
[TBL] [Abstract][Full Text] [Related]
32. Long-term improvement of hematopoiesis following cyclosporine treatment in a patient with myelodysplastic syndrome.
Berer A; Ohler L; Simonitsch I; Thalhammer R; Lechner K; Geissler K
Wien Klin Wochenschr; 1999 Oct; 111(19):815-8. PubMed ID: 10568013
[TBL] [Abstract][Full Text] [Related]
33. [Outcome of immunosuppressive therapy for myelodysplastic syndromes: results of 12 cases from a single institution].
Miyata A; Yasuda Y; Fujii S; Kikuchi T
Rinsho Ketsueki; 2002 Oct; 43(10):911-7. PubMed ID: 12462026
[TBL] [Abstract][Full Text] [Related]
34. A retrospective analysis of long-term survival in severe aplastic anemia patients treated with allogeneic bone marrow transplantation or immunosuppressive therapy with antithymocyte globulin and cyclosporin A at a single institution.
Ellis RJ; Kahn Q; Skikne BS; Mayo MS; Allgood JW; Bodensteiner DM; Deauna-Limayo D; Cook JD
Mil Med; 2002 Jul; 167(7):541-5. PubMed ID: 12125844
[TBL] [Abstract][Full Text] [Related]
35. [Combination of rabbit antithymocyte globulin and cyclosporine A as first-line therapy for adult severe aplastic anemia].
Cao HM; Wang HJ; Zhang L; Jing LP; Zhou K; Yang DL; Li HQ; Liu QG; Yan ZS; Liu YZ; Wu YH; Chu YL; Zhang FK
Zhonghua Xue Ye Xue Za Zhi; 2011 Jan; 32(1):38-42. PubMed ID: 21429400
[TBL] [Abstract][Full Text] [Related]
36. [Immunosuppressive treatment of the myelodysplastic syndrome].
Larsen MS; Hasselbalch HC
Ugeskr Laeger; 2003 Jun; 165(26):2654-7. PubMed ID: 12886548
[TBL] [Abstract][Full Text] [Related]
37. Pilot study using tacrolimus rather than cyclosporine plus antithymocyte globulin as an immunosuppressive therapy regimen option for severe aplastic anemia in adults.
Zhu X; Guan J; Xu J; Wei J; Jiang L; Yin J; Zhao L; Zhang Y
Blood Cells Mol Dis; 2014 Sep; 53(3):157-60. PubMed ID: 24931461
[TBL] [Abstract][Full Text] [Related]
38. Comparison of long-term outcome of children with severe aplastic anemia treated with immunosuppression versus bone marrow transplantation.
Gillio AP; Boulad F; Small TN; Kernan NA; Reyes B; Childs BH; Brochstein JA; Laver J; Castro-Malaspina H; O'Reilly RJ
Biol Blood Marrow Transplant; 1997 Apr; 3(1):18-24. PubMed ID: 9209737
[TBL] [Abstract][Full Text] [Related]
39. Outcome of children with aplastic anemia treated with immunosuppressive therapy.
Pongtanakul B; Das PK; Charpentier K; Dror Y
Pediatr Blood Cancer; 2008 Jan; 50(1):52-7. PubMed ID: 17941069
[TBL] [Abstract][Full Text] [Related]
40. Eltrombopag in Combination with Rabbit Anti-thymocyte Globulin/Cyclosporine A in Immunosuppressive Therapy-naïve Patients with Aplastic Anemia in Japan.
Imada K; Obara N; Iida H; Imajo K; Maeda T; Usuki K; Fanghong Z; Hombo Y; Tajima T; Kumagai A; Matsuda A; Nakao S
Intern Med; 2021 Apr; 60(8):1159-1168. PubMed ID: 33229810
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]